DNA hypermethylation of IRX4 is a frequent event that may confer growth advantage to pancreatic cancer cells

被引：3
|
作者：
Chakma, Kanchan [1 ]
Gu, Zhaodi [2 ]
Motoi, Fuyuhiko [3 ]
Unno, Michiaki [3 ]
Horii, Akira [2 ]
Fukushige, Shinichi [2 ]
机构：
[1] Univ Chittagong, Dept Biochem & Mol Biol, Chittagong, Bangladesh
[2] Tohoku Univ, Dept Mol Pathol, Sch Med, Sendai, Miyagi, Japan
[3] Tohoku Univ, Dept Gastroenterol Surg, Sch Med, Sendai, Miyagi, Japan
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-821
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
821
引用
收藏
页数：2
相关论文
共 50 条
  • [31] LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways
    Tong, WG
    Ding, XZ
    Talamonti, MS
    Bell, RH
    Adrian, TE
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 335 (03) : 949 - 956
  • [32] MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1
    Rachagani, Satyanarayana
    Macha, Muzafar A.
    Ponnusamy, Moorthy P.
    Haridas, Dhanya
    Kaur, Sukhwinder
    Jain, Maneesh
    Batra, Surinder K.
    CARCINOGENESIS, 2012, 33 (10) : 1953 - 1964
  • [33] DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Kruppel-Like Factor 4 Expression
    Xie, Victoria K.
    Li, Zhiwei
    Yan, Yongmin
    Jia, Zhiliang
    Zuo, Xiangsheng
    Ju, Zhenlin
    Wang, Jing
    Du, Jiawei
    Xie, Dacheng
    Xie, Keping
    Wei, Daoyan
    CLINICAL CANCER RESEARCH, 2017, 23 (18) : 5585 - 5597
  • [34] Critical role of hnRNP Al in activating KRAS transcription in pancreatic cancer cells: A molecular mechanism involving G4 DNA
    Cogoi, Susanna
    Rapozzi, Valentina
    Cauci, Sabina
    Xodo, Luigi E.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2017, 1861 (05): : 1389 - 1398
  • [35] 4-Hydroxy-17-methylincisterol, an inhibitor of DNA polymerase-α activity and the growth of human cancer cells in vitro
    Togashi, H
    Mizushina, Y
    Takemura, M
    Sugawara, F
    Koshino, H
    Esumi, Y
    Uzawa, J
    Kumagai, H
    Matsukage, A
    Yoshida, S
    Sakaguchi, K
    BIOCHEMICAL PHARMACOLOGY, 1998, 56 (05) : 583 - 590
  • [36] Epidermal Growth Factor Receptor-Targeted Gelatin-Based Engineered Nanocarriers for DNA Delivery and Transfection in Human Pancreatic Cancer Cells
    Padmaja Magadala
    Mansoor Amiji
    The AAPS Journal, 10
  • [37] Epidermal Growth Factor Receptor-Targeted Gelatin-Based Engineered Nanocarriers for DNA Delivery and Transfection in Human Pancreatic Cancer Cells
    Magadala, Padmaja
    Amiji, Mansoor
    AAPS JOURNAL, 2008, 10 (04): : 565 - 576
  • [38] Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells
    Abdelrahim, Maen
    Baker, Cheryl H.
    Abbruzzese, James L.
    Sheikh-Hamad, David
    Liu, Shengxi
    Cho, Sung Dae
    Yoon, Kyungsil
    Safe, Stephen
    CANCER RESEARCH, 2007, 67 (07) : 3286 - 3294
  • [39] Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor targeted therapy.
    Itakura, J
    Funatomi, H
    Ishiwata, T
    Korc, M
    GASTROENTEROLOGY, 1997, 112 (04) : A450 - A450
  • [40] Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy
    Funatomi, H
    Itakura, J
    Ishiwata, T
    Pastan, I
    Thompson, SA
    Johnson, GR
    Korc, M
    INTERNATIONAL JOURNAL OF CANCER, 1997, 72 (03) : 512 - 517
12345